Evidence map›Paper›PMID 32333241›Full record

ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2020

Dehydroeffusol Rescues Amyloid β

Toshiyuki Fukuda, Yuichi Sato, Mako Takiguchi, Takahiro Yamamoto, Hiroyasu Murasawa, Akiko Pawlak, Hiroyuki Kobayashi, Haruna Tamano, Atsushi Takeda

Abstract read
PubMed Publisher
In one paragraph

Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Dehydroeffusol Pprevents Amyloid βMolecular neurobiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Toshiyuki FukudaSatoen CO., LTD., 1057 Ohhara, Aoi-ku, Shizuoka, 421-1392, Japan.
Yuichi SatoDepartment of Neurophysiology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
Mako TakiguchiDepartment of Neurophysiology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
Takahiro YamamotoDepartment of Neurophysiology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
Hiroyasu MurasawaHashima Laboratory, Nihon Bioresearch Inc, 6-104, Majima, Fukuju-cho, Hashima, Gifu, 501-6251, Japan.
Akiko PawlakHashima Laboratory, Nihon Bioresearch Inc, 6-104, Majima, Fukuju-cho, Hashima, Gifu, 501-6251, Japan.
Hiroyuki KobayashiHashima Laboratory, Nihon Bioresearch Inc, 6-104, Majima, Fukuju-cho, Hashima, Gifu, 501-6251, Japan.
Haruna TamanoDepartment of Neurophysiology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
Atsushi TakedaDepartment of Neurophysiology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. takedaa@u-shizuoka-ken.ac.jp.
University of Shizuoka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid β (Aβ) peptides produced from the amyloid precursor protein, a transmembrane protein, are neurotoxic and blocking the neurotoxicity may lead to prevention of Alzheimer's disease (AD). Here we tested whether Aβ

Indexed as

Alzheimer DiseasePhenanthrenesAmyloid beta-PeptidesAnimalsDisease Models, AnimalMaze LearningMemory DisordersMicePeptide FragmentsAmyloid beta-PeptidesdehydroeffusolPeptide FragmentsPhenanthrenesAlzheimer’s diseaseAmyloid β25–35DehydroeffusolJuncus effususMemory

Identifiers

PMID32333241
OpenAlexW3018549954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.